FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

D. W. Wu, M. C. Lee, N. Y. Hsu, T. C. Wu, J. Y. Wu, Y. C. Wang, Y. W. Cheng, C. Y. Chen, H. Lee

Research output: Contribution to journalArticle

33 Citations (Scopus)

Fingerprint Dive into the research topics of 'FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction'. Together they form a unique fingerprint.

Medicine & Life Sciences